December 16, 2019
Shionogi said on December 13 that it has completed a tender offer for UMN Pharma, making the Japanese vaccine developer its consolidated subsidiary, effective December 19. In October, Shionogi announced the acquisition of UMN, in which the Osaka-based drug maker...read more